Cargando…

Antitumor Activity of DFX117 by Dual Inhibition of c-Met and PI3Kα in Non-Small Cell Lung Cancer

Aberrant activation of hepatocyte growth factor (HGF)/c-Met signaling pathway caused by gene amplification or mutation plays an important role in tumorigenesis. Therefore, c-Met is considered as an attractive target for cancer therapy and c-Met inhibitors have been developed with great interests. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Yanhua, Ding, Huaiwei, Kim, Donghwa, Bach, Duc-Hiep, Hong, Ji-Young, Xu, Yongnan, Lee, Sang Kook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562471/ https://www.ncbi.nlm.nih.gov/pubmed/31060329 http://dx.doi.org/10.3390/cancers11050627

Ejemplares similares

A DFX-based iron nanochelator for cancer therapy
por: Liu, Peng, et al.
Publicado: (2022)

The Dual Role of Bone Morphogenetic Proteins in Cancer
por: Bach, Duc-Hiep, et al.
Publicado: (2017)

Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy
por: Soliman, Ashraf, et al.
Publicado: (2014)

Delafloxacin-Capped Gold Nanoparticles (DFX-AuNPs): An Effective Antibacterial Nano-Formulation of Fluoroquinolone Antibiotic
por: Abu Lila, Amr Selim, et al.
Publicado: (2022)

BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells
por: Bach, Duc-Hiep, et al.
Publicado: (2018)

AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells
por: Kim, Donghwa, et al.
Publicado: (2019)

Dual blocking of PI3K and mTOR signaling by DHW‐221, a novel benzimidazole derivative, exerts antitumor activity in human non‐small cell lung cancer
por: Qin, Xiaochun, et al.
Publicado: (2021)

Circular RNAs in Cancer
por: Bach, Duc-Hiep, et al.
Publicado: (2019)

Overexpression of PI3K p110α contributes to acquired resistance to MET inhibitor, in MET-amplified SNU-5 gastric xenografts
por: Ji, Fujian, et al.
Publicado: (2015)

Salternamide A Suppresses Hypoxia-Induced Accumulation of HIF-1α and Induces Apoptosis in Human Colorectal Cancer Cells
por: Bach, Duc-Hiep, et al.
Publicado: (2015)

Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells
por: Bach, Duc-Hiep, et al.
Publicado: (2018)

The Role of PI3K in Met Driven Cancer: A Recap
por: Hervieu, Alexia, et al.
Publicado: (2018)

isospin analysis of the reaction $\pi^{+}$ p -> $\pi$ (N $\pi$) at 11.7 GeV/c
por: Evans, D, et al.
Publicado: (1974)

NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells
por: MOON, DU G., et al.
Publicado: (2014)

Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2014)

Antitumor activity of a novel dual functional podophyllotoxin derivative involved PI3K/AKT/mTOR pathway
por: Li, Yongli, et al.
Publicado: (2019)

The Role of Platelets in the Tumor-Microenvironment and the Drug Resistance of Cancer Cells
por: Huong, Phung Thanh, et al.
Publicado: (2019)

Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer
por: Lin, Xiaoting, et al.
Publicado: (2019)

Design, Synthesis and Antitumor Activity of Novel Selenium-Containing Tepotinib Derivatives as Dual Inhibitors of c-Met and TrxR
por: Hu, Jinhui, et al.
Publicado: (2023)

Integrin αIIb-Mediated PI3K/Akt Activation in Platelets
por: Niu, Haixia, et al.
Publicado: (2012)

Formation of $^{117}In-H$ pairs after annealing of GaN implanted with $^{117}Cd(^{117}In)$
por: Dietrich, M, et al.
Publicado: (2001)

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer
por: ZHANG, CHANG-HUA, et al.
Publicado: (2013)

Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer
por: Zhu, Yan, et al.
Publicado: (2015)

Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells()
por: Wu, Y. Linda, et al.
Publicado: (2017)

Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells
por: Murase, Yusuke, et al.
Publicado: (2022)

Decay study of the $^{117}$Cs and $^{117}$Xe nuclei
por: Marguier, G, et al.
Publicado: (1985)

Dual + Pomeron analysis of $\ K ^{+} {-} p\rightarrow\K ^{+}{-} pi ^{0}p $
por: Kajantie, Keijo, et al.
Publicado: (1970)

Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells
por: Rexer, Brent N, et al.
Publicado: (2014)

The reaction $\pi^{+}$ p -> $\omega \delta^{++}$ (1236) at 11.7 GeV/c
por: Evans, D, et al.
Publicado: (1973)

Antiproliferative Activity of a New Quinazolin-4(3H)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer
por: Lee, Ji Yun, et al.
Publicado: (2022)

The Dominant Role of Forkhead Box Proteins in Cancer
por: Bach, Duc-Hiep, et al.
Publicado: (2018)

6-Gingerol Activates PI3K/Akt and Inhibits Apoptosis to Attenuate Myocardial Ischemia/Reperfusion Injury
por: Lv, Xiangwei, et al.
Publicado: (2018)

Novel Peptide CM 7 Targeted c-Met with Antitumor Activity
por: Xia, Chunlei, et al.
Publicado: (2020)

PI3Kα Inhibitors That Inhibit Metastasis
por: Schmidt-Kittler, Oleg, et al.
Publicado: (2010)

The role of PI3Kα isoform in cardioprotection
por: Rossello, Xavier, et al.
Publicado: (2017)

Coherent production of two, three, four and five $\pi$ mesons by $\pi^{+}$ nuclei interactions at 11.7 GeV/c
por: Arnold, R, et al.
Publicado: (1973)

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2014)

In vitro assessment of antitumor activities of the PI3K/mTOR inhibitor GSK2126458
por: Albawardi, Alia, et al.
Publicado: (2014)

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
por: Namatame, Nachi, et al.
Publicado: (2018)

Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
por: Lauder, Sarah Nicol, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nf39pc4928hgcn6inttf84ungh